These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6134063)

  • 21. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability?
    De Nicola L; Minutolo R; Conte G
    Nephron Clin Pract; 2010; 114(4):c236-41. PubMed ID: 20090364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibronectin in patients with chronic renal failure undergoing dialysis].
    Hou FF; Zhang X
    Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):348-51, 389. PubMed ID: 3197506
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between anemia and adequacy of continuous ambulatory peritoneal dialysis.
    Opatrná S; Opatrný K; Cejková P; Sefrna F; Hostasová A; Opatrný K
    Nephron; 1997; 77(3):359-60. PubMed ID: 9375834
    [No Abstract]   [Full Text] [Related]  

  • 28. Anaemia in high-efficiency dialysis.
    Mastrangelo F; Alfonso L; Rizzelli S; Aprile M; Sandri L
    Nephrol Dial Transplant; 1991; 6 Suppl 2():116-21. PubMed ID: 1866060
    [No Abstract]   [Full Text] [Related]  

  • 29. [Utilization of EPO in CAPD].
    Ramello A; Perosa P; Bruno M; Reina E; Rizzuto A; Bertasso L; Roggero A; Malcangi U
    Minerva Urol Nefrol; 1991; 43(3):137-41. PubMed ID: 1817335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA Registry.
    Geerlings W; Morris RW; Brunner FP; Brynger H; Ehrich JH; Fassbinder W; Rizzoni G; Selwood NH; Tufveson G; Wing AJ
    Nephrol Dial Transplant; 1993; 8(7):585-9. PubMed ID: 8396740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
    Radovanović Lj; Popović J; Radlović O
    Srp Arh Celok Lek; 1988; 116(11-12):967-76. PubMed ID: 3247614
    [No Abstract]   [Full Text] [Related]  

  • 32. Red blood cell survival in long-term dialysis patients.
    Vos FE; Schollum JB; Coulter CV; Doyle TC; Duffull SB; Walker RJ
    Am J Kidney Dis; 2011 Oct; 58(4):591-8. PubMed ID: 21715072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of human recombinant erythropoietin therapy on protein metabolism of patients with terminal renal failure on hemodialysis].
    Scigalla P; Fischer C; Park W; Becker H; Schiller R; Paust H; Brösicke H; Kessel M
    Beitr Infusionsther; 1990; 25():430-8. PubMed ID: 1690065
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis.
    Johnson R; McNutt P; MacMahon S; Robson R
    Clin Chem; 1997 Nov; 43(11):2183-4. PubMed ID: 9365406
    [No Abstract]   [Full Text] [Related]  

  • 35. Continuous ambulatory peritoneal dialysis.
    Maher JF; Maher AT
    Am Fam Physician; 1989 Nov; 40(5):187-92. PubMed ID: 2683690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
    Zehnder C
    Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal replacement therapy. 4-2. Continuous ambulatory peritoneal dialysis--an alternative approach in maintenance dialysis therapy.
    Wood A
    Nurs Times; 1982 May 19-25; 78(20):852-4. PubMed ID: 6919909
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of human recombinant erythropoietin on plasminogen activator inhibitor, and protein C and S activity.
    Steffensen G; Aunsholt NA
    Am J Nephrol; 1996; 16(5):453-4. PubMed ID: 8886186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.